Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000

Detalles Bibliográficos
Autores principales: Vieira, João, Marcelino, João, Ferreira, Fátima, Farinha, Sofia, Silva, Rita, Proença, Miguel, Tomaz, Elza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2021
Materias:
Hypothesis & Experience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103012/
https://www.ncbi.nlm.nih.gov/pubmed/34007828
http://dx.doi.org/10.5415/apallergy.2021.11.e18
_version_ 1783689227867783168
author Vieira, João
Marcelino, João
Ferreira, Fátima
Farinha, Sofia
Silva, Rita
Proença, Miguel
Tomaz, Elza
author_facet Vieira, João
Marcelino, João
Ferreira, Fátima
Farinha, Sofia
Silva, Rita
Proença, Miguel
Tomaz, Elza
author_sort Vieira, João
collection PubMed
description
format Online
Article
Text
id pubmed-8103012
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Asia Pacific Association of Allergy, Asthma and Clinical Immunology
record_format MEDLINE/PubMed
spelling pubmed-81030122021-05-17 Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000 Vieira, João Marcelino, João Ferreira, Fátima Farinha, Sofia Silva, Rita Proença, Miguel Tomaz, Elza Asia Pac Allergy Hypothesis & Experience Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2021-04-26 /pmc/articles/PMC8103012/ /pubmed/34007828 http://dx.doi.org/10.5415/apallergy.2021.11.e18 Text en Copyright © 2021. Asia Pacific Association of Allergy, Asthma and Clinical Immunology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Hypothesis & Experience
Vieira, João
Marcelino, João
Ferreira, Fátima
Farinha, Sofia
Silva, Rita
Proença, Miguel
Tomaz, Elza
Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000
title Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000
title_full Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000
title_fullStr Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000
title_full_unstemmed Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000
title_short Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000
title_sort skin testing with pfizer sars-cov-2 vaccine and peg 2000
topic Hypothesis & Experience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103012/
https://www.ncbi.nlm.nih.gov/pubmed/34007828
http://dx.doi.org/10.5415/apallergy.2021.11.e18
work_keys_str_mv AT vieirajoao skintestingwithpfizersarscov2vaccineandpeg2000
AT marcelinojoao skintestingwithpfizersarscov2vaccineandpeg2000
AT ferreirafatima skintestingwithpfizersarscov2vaccineandpeg2000
AT farinhasofia skintestingwithpfizersarscov2vaccineandpeg2000
AT silvarita skintestingwithpfizersarscov2vaccineandpeg2000
AT proencamiguel skintestingwithpfizersarscov2vaccineandpeg2000
AT tomazelza skintestingwithpfizersarscov2vaccineandpeg2000

Ejemplares similares